Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 USD | 0.00% | -16.67% | -40.00% |
26/04 | North American Morning Briefing : Tech Still in -2- | DJ |
19/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar ContraFect Corporation
Upcoming events on ContraFect Corporation
Past events on ContraFect Corporation
21/11/2023 | Extraordinary Shareholders Meeting |
23/10/2023 06:30 pm | Extraordinary Shareholders Meeting |
21/09/2023 01:00 am | ASM and ESCMID Joint Conference - Poster Number 007 |
20/09/2023 07:15 pm | ASM and ESCMID Joint Conference - Methodologies on Clinical Development |
07/09/2023 11:45 pm | World Anti Microbial Resistance Congress |
14/08/2023 06:00 pm | Q2 2023 Earnings Release |
21/06/2023 07:30 pm | Maxim Group Virtual Healthcare Conference |
17/06/2023 08:30 pm | ASM Microbe Conference - Poster Number:529 |
17/06/2023 08:30 pm | ASM Microbe Conference - Poster Number:524 |
16/06/2023 08:30 pm | ASM Microbe Conference - Poster Number:487 |
16/06/2023 08:30 pm | ASM Microbe Conference - Poster Number:476 |
16/05/2023 06:30 pm | Annual General Meeting |
15/05/2023 05:30 pm | Q1 2023 Earnings Release |
17/04/2023 03:30 pm | European Clinical Microbiology & Infectious Diseases Meeting - Abstract ID #05341 |
17/04/2023 03:30 pm | European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05336 |
17/04/2023 03:30 pm | European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033 |
17/04/2023 03:30 pm | European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05345 |
15/04/2023 01:00 pm | European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033 |
31/03/2023 06:00 pm | Q4 2022 Earnings Release |
10/02/2023 07:30 pm | Extraordinary Shareholders Meeting |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -34,1 -29,9 -13.95% | -47,1 -43,8 -7.57% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -31,1 -30,2 -2.96% | -27,9 -29,1 4.18% | -34,2 -32,4 -5.73% | -47,3 -44,8 -5.42% | -56,9 -63,4 10.27% | -31,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,7 -51,5 26.79% | -12,8 -10,1 -26.92% | -28,2 -32,8 14.13% | -20,3 -29,0 30.02% | -65,2 -60,8 -7.16% | -23,4 |
Net income Million USD | Released Forecast Spread | -37,7 -51,5 26.79% | -12,8 -10,1 -26.92% | -28,2 -32,8 14.13% | -20,3 -28,1 27.74% | -65,2 -60,8 -7.16% | -23,4 |
EPS USD | Released Forecast Spread | -400 -542 26.25% | -123 -90,6 -35.98% | -99,2 -122 18.74% | -44,0 -60,8 27.63% | -125 -124 -0.78% | -3,44 |
Announcement Date | 14/03/19 | 18/03/20 | 30/03/21 | 24/03/22 | 31/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -11,7 -11,0 -6.68% | -14,1 -11,3 -24.51% | -16,0 -11,9 -34.28% | -20,0 -14,2 -41.28% | -14,2 -12,6 -12.54% | -6,70 -13,2 49.22% | -8,86 -6,50 -36.28% | -7,98 -6,70 -19.03% | -6,68 -7,10 5.96% | -7,40 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,29 -10,8 51.02% | -4,40 -11,1 60.52% | -20,2 -11,9 -69.39% | -18,1 -14,2 -27.61% | -17,1 -12,6 -35.45% | -9,84 -13,2 25.46% | -1,37 -6,50 78.91% | -7,57 -6,70 -12.96% | -5,36 -7,10 24.52% | -7,40 |
Net income Million USD | Released Forecast Spread | -5,29 -10,8 51.02% | -4,40 -10,5 58.03% | -20,2 -11,9 -69.39% | -18,1 -13,0 -39.32% | -17,1 -10,2 -67.32% | -9,84 -13,2 25.46% | -1,37 -6,50 78.91% | -7,57 -6,70 -12.96% | -5,36 -7,10 24.52% | -7,40 |
EPS USD | Released Forecast Spread | -10,4 -22,4 53.57% | -8,80 -22,4 60.71% | -40,8 -23,8 -71.43% | -36,8 -26,4 -39.39% | -34,4 -18,4 -86.96% | -16,1 -27,2 40.66% | -0,69 -10,8 93.63% | -1,94 -1,81 -7.18% | -0,50 -0,66 24.24% | -0,69 |
Announcement Date | 15/11/21 | 24/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | - |
Past sector events for ContraFect Corporation
Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CFRXQ Stock
- Calendar ContraFect Corporation